INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 437m ago
HOUSE PTR36m ago
SEC 13F36m ago
ROBINHOOD CHAIN36m ago
Public company

ABTABBOTT LABORATORIES

CIK 0000001800

EDGAR filingsOpen in network
Disclosed transactions40
Buys / sells7 / 15
Max Insider Score44
Connections30with evidence

ABT · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
Thomas H. Kean, Jr.RSelf
ABTABBOTT LABORATORIES
Partial sale
SELL$1,001 – $15KSep 17, 2026Oct 30, 2026
traded Sep 17, 2026
+43dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Connected organizationevidence
    ABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEEFEC Form 1 connected organization: ABBOTT LABORATORIES (curated map) · Nov 4, 2026
  • ← Disclosed trade inevidence
    Thomas H. Kean, Jr.Sale disclosed 2026-10-30 · Oct 30, 2026
  • ← Disclosed trade inevidence
    Pete SessionsSale disclosed 2026-10-27 · Oct 27, 2026
30
Pete SessionsRSpouse
ABTABBOTT LABORATORIES
Sale
SELL
$50K – $100K
Oct 2, 2026
Oct 27, 2026
traded Oct 2, 2026
+25d
HOUSE PTR

Evidence

20
Gilbert Ray Cisneros, Jr.DSelf
ABTABBOTT LABORATORIES
Purchase
BUY$1,001 – $15KSep 18, 2026Oct 12, 2026
traded Sep 18, 2026
+24dHOUSE PTR

Evidence

34
Rick W. AllenRSpouse
ABTABBOTT LABORATORIES
Sale
SELL$15K – $50KJul 14, 2026Aug 18, 2026
traded Jul 14, 2026
+35dHOUSE PTR

Evidence

37
RM
Richard Dean McCormickSelf
ABTABBOTT LABORATORIES
Sale
SELL$1,001 – $15KJul 30, 2026Aug 14, 2026
traded Jul 30, 2026
+15dHOUSE PTR

Evidence

36
MH
Morrone Louis H.EXECUTIVE VICE PRESIDENT
ABTABBOTT LABORATORIES
Open-market sale
SELL$643K
5,850 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

8
MH
Morrone Louis H.EXECUTIVE VICE PRESIDENT
ABTABBOTT LABORATORIES
Discretionary transaction
I$1,296
12 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

35
Mike KellyRSpouse
ABTABBOTT LABORATORIES
Sale
SELL$1,001 – $15KJul 17, 2026Aug 12, 2026
traded Jul 17, 2026
+26dHOUSE PTR

Evidence

30
Rick LarsenDSelf
ABTABBOTT LABORATORIES
Sale
SELL$1,001 – $15KJul 8, 2026Jul 12, 2026
traded Jul 8, 2026
+4dHOUSE PTR

Evidence

25
RM
Richard Dean McCormickSelf
ABTABBOTT LABORATORIES
Purchase
BUY$1,001 – $15KJun 12, 2026Jul 9, 2026
traded Jun 12, 2026
+27dHOUSE PTR

Evidence

25
RM
Richard Dean McCormickSelf
ABTABBOTT LABORATORIES
Purchase
BUY$1,001 – $15KJun 12, 2026Jul 9, 2026
traded Jun 12, 2026
+27dHOUSE PTR

Evidence

36
Gilbert Ray Cisneros, Jr.DSelf
ABTABBOTT LABORATORIES
Purchase
BUY$1,001 – $15KJun 16, 2026Jul 2, 2026
traded Jun 16, 2026
+16dHOUSE PTR

Evidence

21
AN
Ahuja NitaDirector
ABTABBOTT LABORATORIES
Grant or award
A$31K
347 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

13
GP
Gonzalez Patricia PaolaDirector
ABTABBOTT LABORATORIES
Grant or award
A$33K
363 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC FORM 4

Evidence

8
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Tax withholding
F$53K
560 sh
Jun 27, 2026Jun 29, 2026
traded Jun 27, 2026
+2dSEC FORM 4

Evidence

29
Julie JohnsonDJoint
ABTABBOTT LABORATORIES
Sale
SELL$1,001 – $15KMay 12, 2026Jun 12, 2026
traded May 12, 2026
+31dHOUSE PTR

Evidence

26
Gilbert Ray Cisneros, Jr.DSelf
ABTABBOTT LABORATORIES
Sale
SELL$1,001 – $15KMay 15, 2026Jun 8, 2026
traded May 15, 2026
+24dHOUSE PTR

Evidence

39
Rick W. AllenRSpouse
ABTABBOTT LABORATORIES
Sale
SELL$15K – $50KApr 16, 2026Jun 5, 2026
traded Apr 16, 2026
+50dHOUSE PTR

Evidence

25
Josh GottheimerDJoint
ABTABBOTT LABORATORIES
Partial sale
SELL$1,001 – $15KMay 27, 2026Jun 3, 2026
traded May 27, 2026
+7dHOUSE PTR

Evidence

26
MK
Moreland Mary KEXECUTIVE VICE PRESIDENT
ABTABBOTT LABORATORIES
Discretionary transaction
I$502K
5,314 sh
Apr 28, 2026Apr 29, 2026
traded Apr 28, 2026
+1dSEC FORM 4

Evidence

9
AN
Ahuja NitaDirector
ABTABBOTT LABORATORIES
Grant or award
A—
2,286 sh
Apr 24, 2026Apr 28, 2026
traded Apr 24, 2026
+4dSEC FORM 4

Evidence

17
GP
Gonzalez Patricia PaolaDirector
ABTABBOTT LABORATORIES
Grant or award
A—
2,286 sh
Apr 24, 2026Apr 28, 2026
traded Apr 24, 2026
+4dSEC FORM 4

Evidence

17
MW
McDew Darren WDirector
ABTABBOTT LABORATORIES
Grant or award
A—
2,286 sh
Apr 24, 2026Apr 28, 2026
traded Apr 24, 2026
+4dSEC FORM 4

Evidence

17
BC
Babineaux-Fontenot ClaireDirector
ABTABBOTT LABORATORIES
Grant or award
A—
2,286 sh
Apr 24, 2026Apr 28, 2026
traded Apr 24, 2026
+4dSEC FORM 4

Evidence

44
BP
Boudreau Philip PEVP AND CFO
ABTABBOTT LABORATORIES
Open-market purchase
BUY$201K
2,200 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

30
BP
Boudreau Philip PEVP AND CFO
ABTABBOTT LABORATORIES
Discretionary transaction
I$820K
8,909 sh
Apr 23, 2026Apr 27, 2026
traded Apr 23, 2026
+4dSEC FORM 4

Evidence

14
Laura FriedmanDSelf
ABTABBOTT LABORATORIES
Exchange
EXCH$1,001 – $15KMar 24, 2026Apr 17, 2026
traded Mar 24, 2026
+24dHOUSE PTR

Evidence

24
RM
Richard Dean McCormickSelf
ABTABBOTT LABORATORIES
Purchase
BUY$1,001 – $15KMar 19, 2026Apr 7, 2026
traded Mar 19, 2026
+19dHOUSE PTR

Evidence

9
AN
Ahuja NitaDirector
ABTABBOTT LABORATORIES
Grant or award
A$10K
102 sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

20
Gilbert Ray Cisneros, Jr.DSelf
ABTABBOTT LABORATORIES
Partial sale
SELL$1,001 – $15KFeb 10, 2026Mar 9, 2026
traded Feb 10, 2026
+27dHOUSE PTR

Evidence

12
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Tax withholding
F$165K
1,421 sh
Feb 27, 2026Mar 3, 2026
traded Feb 27, 2026
+4dSEC FORM 4

Evidence

25
SE
Shroff EricSenior Vice President
ABTABBOTT LABORATORIES
Open-market sale
SELL$82K
709 sh
Mar 2, 2026Mar 3, 2026
traded Mar 2, 2026
+1dSEC FORM 4

Evidence

8
SE
Shroff EricSenior Vice President
ABTABBOTT LABORATORIES
Tax withholding
F$161K
1,384 sh
Feb 27, 2026Mar 3, 2026
traded Feb 27, 2026
+4dSEC FORM 4

Evidence

26
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Open-market sale
SELL$30K
263 sh
Mar 2, 2026Mar 3, 2026
traded Mar 2, 2026
+1dSEC FORM 4

Evidence

13
SE
Shroff EricSenior Vice President
ABTABBOTT LABORATORIES
Grant or award
A—
10.9K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

5
SE
Shroff EricSenior Vice President
ABTABBOTT LABORATORIES
Grant or award
A—
44.8K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

21
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Grant or award
A—
15.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

9
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Grant or award
A—
62.0K sh
Feb 24, 2026Feb 26, 2026
traded Feb 24, 2026
+2dSEC FORM 4

Evidence

24
Thomas H. Kean, Jr.RSelf
ABTABBOTT LABORATORIES
Purchase
BUY$1,001 – $15KJan 29, 2026Feb 19, 2026
traded Jan 29, 2026
+21dHOUSE PTR

Evidence

24
SE
Shroff EricSenior Vice President
ABTABBOTT LABORATORIES
Open-market sale
SELL$203K
1,586 sh
Nov 25, 2025Nov 25, 2025
traded Nov 25, 2025
+0dSEC FORM 4

Evidence

  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-10-12 · Oct 12, 2026
  • ← Lobbied forevidence
    AKIN GUMP STRAUSS HAUER & FELDLDA Q1 2026 first quarter · Trade · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q1 2026 first quarter · Budget/appropriations, FOR · Aug 26, 2026
  • ← Lobbied forevidence
    W STRATEGIES, LLCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    S-3 GROUPLDA Q1 2026 first quarter · Agriculture, Medicare/Medicaid, Health issues, Taxation · Aug 26, 2026
  • ← Lobbied forevidence
    FEDERAL HEALTH POLICY STRATEGIESLDA Q1Y 2026 first quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    MAYER BROWN LLPLDA Q2 2026 second quarter · Taxation · Aug 26, 2026
  • ← Lobbied forevidence
    PHRONESISDC, LLCLDA Q2 2026 second quarter · Taxation, RET · Aug 26, 2026
  • ← Lobbied forevidence
    MARSHALL & POPP, LLCLDA Q1 2026 first quarter · Agriculture, Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    KOUNTOUPES DENHAM CARR & REID, LLCLDA Q2 2026 second quarter · FOO, Taxation, Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Morrone Louis H.EXECUTIVE VICE PRESIDENT · Aug 13, 2026
  • ← Disclosed trade inevidence
    Mike KellySale disclosed 2026-08-12 · Aug 12, 2026
  • ← Disclosed trade inevidence
    Rick LarsenSale disclosed 2026-07-12 · Jul 12, 2026
  • ← Disclosed trade inevidence
    Julie JohnsonSale disclosed 2026-06-12 · Jun 12, 2026
  • ← Disclosed trade inevidence
    Rick W. AllenSale disclosed 2026-06-05 · Jun 5, 2026
  • ← Disclosed trade inevidence
    Josh GottheimerSale disclosed 2026-06-03 · Jun 3, 2026
  • ← Insider ofevidence
    Moreland Mary KEXECUTIVE VICE PRESIDENT · Apr 29, 2026
  • ← Insider ofevidence
    Gonzalez Patricia PaolaDirector · Apr 28, 2026
  • ← Insider ofevidence
    McDew Darren WDirector · Apr 28, 2026
  • ← Insider ofevidence
    Babineaux-Fontenot ClaireDirector · Apr 28, 2026
  • ← Insider ofevidence
    Boudreau Philip PEVP AND CFO · Apr 27, 2026
  • ← Disclosed trade inevidence
    Laura FriedmanExchange disclosed 2026-04-17 · Apr 17, 2026
  • ← Disclosed trade inevidence
    Richard Dean McCormickPurchase disclosed 2026-04-07 · Apr 7, 2026
  • ← Insider ofevidence
    Ahuja NitaDirector · Apr 2, 2026
  • ← Insider ofevidence
    Cushman Elizabeth C.EVP, GC AND SECRETARY · Feb 26, 2026
  • ← Insider ofevidence
    Shroff EricSenior Vice President · Nov 25, 2025

    • Lobbying

    $2.56M reported · de-duplicated
    2026 Q2 $1.15M in-house2026 Q1 $1.41M in-house
    • In-house report$1.15M2026 Q2 · posted Aug 26, 2026 · Budget/appropriations, TAR, Consumer issues, Health issues, Medicare/Medicaid, Trade, LAW, FOO
    • FEDERAL HEALTH POLICY STRATEGIES—2026 Q2 · posted Aug 26, 2026 ·
    • TIBER CREEK GROUP$50K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations, FOR
    • S-3 GROUP$60K2026 Q1 · posted Aug 26, 2026 · Agriculture, Medicare/Medicaid, Health issues, Taxation
    • S-3 GROUP$60K2026 Q2 · posted Aug 26, 2026 · Agriculture, Medicare/Medicaid, Health issues, Taxation
    • W STRATEGIES, LLC$50K2026 Q2 · posted Aug 26, 2026 · Health issues
    • AKIN GUMP STRAUSS HAUER & FELD$60K2026 Q2 · posted Aug 26, 2026 · Trade
    • W STRATEGIES, LLC$50K2026 Q1 · posted Aug 26, 2026 · Health issues
    • MARSHALL & POPP, LLC$60K2026 Q2 · posted Aug 26, 2026 · Agriculture, Medicare/Medicaid, Taxation, Defense
    • In-house report$1.41M2026 Q1 · posted Aug 26, 2026 · Taxation, LAW, FOO, Budget/appropriations, Financial institutions, TAR, Health issues, Medicare/Medicaid, Trade, Agriculture
    • MAYER BROWN LLP—2026 Q2 · posted Aug 26, 2026 · Taxation
    • PHRONESISDC, LLC—2026 Q2 · posted Aug 26, 2026 · RET, Taxation, Health issues, TOR

    Connected PAC contributions

    FEC · direct to members
    • Julia LetlowR$13KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
    • Diana HarshbargerR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
    • Pete AguilarD$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
    • Mike CareyR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
    • Steven HorsfordD$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
  • Kevin HernR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
  • Brett GuthrieR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
  • Troy BaldersonR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
  • Nikki BudzinskiD$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
  • Susan M. CollinsR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
  • John CornynR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE
  • Jon HustedR$10KABBOTT LABORATORIES EMPLOYEE POLITICAL ACTION COMMITTEE